RT @DrCassySims: Xeljanz use in AS #ACR22 (@pfizer sponsored) @RheumNow -Included patients with at least bilateral gra

Catherine Sims, MD @DrCassySims Nov 12, 2022

Xeljanz use in AS #ACR22 (@pfizer sponsored) @RheumNow

-Included patients with at least bilateral grade 2 SI or grade 3/4 unilateral SI
-5mg BID Xeljanz
-Significantly more patients had ASAS20/40 response, CRP reduction, & QOL, vs. placebo
-Onset of action noticed at 2 weeks